Optimizing Tumor-Stromal Exosome Dose for Enhanced Proliferation in MDA-MB-231 Breast Cancer Cells
Fateme hanifi,1Mina ramezani,2,*
1. Department of Biology, Central Tehran Branch, Islamic Azad University, Ashrafi Isfahani Highway, Imam Hassan Blvd., Tehran, Iran. 2. Department of Biology, Central Tehran Branch, Islamic Azad University, Ashrafi Isfahani Highway, Imam Hassan Blvd., Tehran, Iran.
Introduction: Abstract
Background and Aim: Exosomes shed by stromal cells within the tumor microenvironment are
major players in intercellular communication and are known to influence the biological behavior
of cancer cells, particularly their proliferation rates. This study set out to establish the optimal dose
of tumor-derived stromal exosomes for further experimental use by assessing their effects on
MDA-MB-231 breast cancer cell proliferation through the MTT assay.
Methods: MDA-MB-231 cells were grown to 80% confluency, trypsinized, and then seeded into
24-well plates at an optimized density. The cells received 24-hour treatments with exosome
concentrations of 0 (control), 20, 30, and 40 µg/mL, each tested in duplicate. After adding the MTT
reagent and dissolving the formazan crystals in DMSO, we read the absorbance at 490 nm using
an ELISA reader. Proliferation rates were calculated as the fold change relative to the control
group.
Results: Our findings showed that exosome concentrations of 20, 30, and 40 µg/mL boosted cell
proliferation by 2.3-, 3.7-, and 2.5-fold, respectively, compared to the untreated controls. The
strongest proliferative response was clearly seen at 30 µg/mL (3.7-fold increase; p < 0.01).
Interestingly, when the dose was raised to 40 µg/mL, the proliferation rate dropped back to
2.5-fold, suggesting that higher exosome levels might introduce mild toxicity or inhibitory effects.
Conclusion: Based on these data, we selected 30 µg/mL as the ideal concentration of
tumor-stromal exosomes for maximizing MDA-MB-231 cell proliferation, and it was
consequently adopted for subsequent experimental steps. This dose-dependent biphasic pattern
underscores the nuanced crosstalk between breast cancer cells and stromal-derived vesicles.